RP-910

N/A

Report date: 2024/04/28 16:18:14

Base Information

Drug NameRP-910
Drug Alias NameRP910RP-910
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHyperlipidemiasMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesRisen(Shanghai) Pharma Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRisen(Shanghai) Pharma Tech Co LtdRisen (Suzhou) Pharma Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A